3-(3-tert-butylsulfanyl-1-(4-(6-ethoxypyridin-3-yl)benzyl)-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylpropionic acid,
AM 803,
AM-803,
GSK2190915,
FIBOFLAPON,
GSK2190915,
936350-00-4,
UNII-Y1NA96IX3T,
Y1NA96IX3T,
CHEMBL1922660,
Fiboflapon [USAN:INN],
AM803,
AM 803,
AM-803,
Fiboflapon (USAN),
GSK 2190915,
SCHEMBL11820,
DTXSID20239496,
DFQGDHBGRSTTHX-UHFFFAOYSA-N,
GSK2190915B,
BDBM50359080,
ZINC68247071,
AKOS030527019,
CS-3604,
SB16524,
AM-803;Fiboflapon;GSK-2190915,
NCGC00485966-01,
1H-Indole-2-propanoic acid, 3-((1,1-dimethylethyl)thio)-1-((4-(6-ethoxy-3-pyridinyl)phenyl)methyl)-alpha,alpha-Dimethyl-5-((5-methyl-2-pyridinyl)methoxy)-,
HY-15874,
D10069,
3-(3-(tert-butylthio)-1-(4-(6-ethoxypyridin-3-yl)benzyl)-5-((5-methylpyridin-2-yl)methoxy)-1H-indol-2-yl)-2,2-dimethylpropanoic acid,
3-[3-(tert-butylsulfanyl)-1-[4-(6-ethoxy-pyridin-3-yl)benzyl]-5-(5-methyl-pyridin-2-yl-methoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid,
3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoic acid,
A15818,